1
|
Oluwole O, Fashola W, Olopade OB, Odeniyi IA, Fasanmade OA. Outcome of Patients with Common Endocrine Diseases Who Had COVID-19 in two Centers in Lagos, Nigeria: A Cross-Sectional Study. West Afr J Med 2023; 40:435-437. [PMID: 37120804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
BACKGROUND Endocrine diseases are ubiquitous. In our environment, diabetes mellitus (DM), obesity and thyroid disorders represent the most common examples. Diabetes mellitus is a global health problem with a myriad of complications. We sought to evaluate outcome in terms of fatality in those with common endocrine diseases who were infected with COVID-19. AIMS AND OBJECTIVES To determine outcome in terms of mortality in patients with common endocrine diseases who contracted COVID-19. MATERIALS AND METHODS We conducted an observational, descriptive, cross-sectional study with 120 participants drawn from the endocrinology/DM clinic at the Lagos University Teaching Hospital and Serenity Hospital, Surulere (a private medical clinic). Data collected included age, gender, type of endocrine disease, comorbid diseases, and COVID-19 status. Through charts from the medical records department, outcome of participants in terms of mortality was determined. RESULTS Data of 120 subjects were analyzed. There were 61males and 59 females, yielding a male:female ratio of 1:1. Mean age was 58 years and the mode was 46 years. Over half (88) of the patients had diabetes mellitus, 22 had obesity, and 17 had thyroid disorders. The case fatality rate of patients with endocrine diseases who had COVID-19 was 11%, with about 85% of these deaths occurring in the elderly (those aged above 60 years). Ninety-two percent of the patients who died had type 2 DM. Approximately 80% of patients who were infected with COVID-19 had at least one co-morbid disease. CONCLUSION Older age, type 2 diabetes mellitus, and the presence of at least one comorbidity were associated with increased mortality in patients with endocrine diseases who were infected with COVID-19 in our study.
Collapse
Affiliation(s)
- O Oluwole
- Benjamin Carson School of Medicine, College of Health and Medical Sciences, Ogun State, Nigeria.
| | - W Fashola
- General Medicine, Serenity Hospital and Remilekun Memorial Medical Centre, Lagos State, Nigeria
| | - O B Olopade
- Departments of Medicine, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria
| | - I A Odeniyi
- Departments of Medicine, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria
| | - O A Fasanmade
- Departments of Medicine, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria
| |
Collapse
|
2
|
Sano D, Lekakis L, Feng L, Nastoupil L, Jain M, Spiegel J, Dahiya S, Lin Y, Ghobadi A, Lunning M, Hill B, Reagan P, Oluwole O, McGuirk J, Sehgal A, Deol A, Charalambos A, Goy A, Munoz J, Cashen A, Bennani N, Rapoport A, Vose J, Miklos D, Locke F, Neelapu S. SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR-T CONSORTIUM. Hematol Oncol 2019. [DOI: 10.1002/hon.113_2630] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- D. Sano
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L. Lekakis
- Bone Marrow Transplant/Hematology; University Of Miami; Miami United States
| | - L. Feng
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L.J. Nastoupil
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - M.D. Jain
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - J.Y. Spiegel
- Hematology; Stanford University; Stanford United States
| | - S. Dahiya
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - Y. Lin
- Hematology; Mayo Clinic; Rochester United States
| | - A. Ghobadi
- Bone Marrow Transplant; Washington University Medical Campus; Saint Louis United States
| | - M. Lunning
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - B.T. Hill
- Hematology and Medical Oncology; Cleveland Clinic; Cleveland United States
| | - P. Reagan
- Lymphoma; University of Rochester Medical Center/Wilmot Cancer institute; Rochester United States
| | - O. Oluwole
- Hematology and Oncology; Vanderbilt University Medical Center; Nashville United States
| | - J. McGuirk
- Hematological Malignancies and Cellular Therapeutic; The University of Kansas Health System; Kansas City United States
| | - A. Sehgal
- Hematology and Oncology; UPMC Hillman Cancer Center; Pittsburgh United States
| | - A. Deol
- Department of Oncology; Wayne State University/Karmanos Cancer Center; Detroit United States
| | - A. Charalambos
- Hematology and Bone Marrow Transplant; University of California San francisco; San Francisco United States
| | - A.H. Goy
- Hematology and Oncology; Hackensack University Medical Center; Hackensack United States
| | - J. Munoz
- Lymphoma/Myeloma; Banner MD Anderson Cancer Center; Gilbert United States
| | - A. Cashen
- Bone Marrow Transplantation & Leukemia; Washington University Medical School; St. Louis United States
| | - N.N. Bennani
- Hematology; Mayo Clinic; Rochester United States
| | - A.P. Rapoport
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - J.M. Vose
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - D.B. Miklos
- Hematology; Stanford University; Stanford United States
| | - F.L. Locke
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - S.S. Neelapu
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| |
Collapse
|
3
|
Oluwole O. Incidental Prostate Cancer in Radical Prostatectomy Specimens of Patients Treated for Benign Prostatic Hyperplasia (BPH): Histopathology Analysis. J Glob Oncol 2018. [DOI: 10.1200/jgo.18.57700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Background: The incidence of prostate cancer (Pca) is the first in malignant tumors among men in the United States, and mortality rate is the second cause of deaths. Incidental prostate cancer is defined as clinically inapparent tumor that is neither palpable nor visible by imaging. Incidental carcinoma is found in 3%-16% of pathology specimens of patients undergoing BPH surgery and it involves less than 5% of resected tissue. Aim: To identify incidentally detected prostate cancer in benign prostatic specimens submitted for histopathology Methods: This is a ten-year retrospective histopathology study of all prostate cancer cases diagnosed between 1991-2000 in the department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Haematoxylin & eosin stained histology slides were retrieved and studied. Institution review board (IRB) approval was obtained from the Teaching Hospital to undertake this study. Results: A total of 67 patients had benign prostatic hyperplasia; the patients' age ranged from 30-75 years with a mean age of 52.5 years. The peak age at diagnosis was in the fifth decade. 26 (38.8%) patients had incidental carcinoma. All the tumors were adenocarcinoma and moderately differentiated. Two patients in their fourth decade were found to have incidental prostate cancer. Conclusion: Incidental prostate cancer is common in patients' undergoing radical prostatectomy for BPH, a high index of suspicion, adequate histopathology training and histopathologic evaluation is critical to diagnosis.
Collapse
|
4
|
Neelapu S, Locke F, Bartlett N, Lekakis L, Miklos D, Jacobson C, Braunschweig I, Oluwole O, Siddiqi T, Lin Y, Timmerman J, Reagan P, Navale L, Jiang Y, Aycock J, Elias M, Wiezorek J, Go W. AXICABTAGENE CILOLEUCEL (AXI-CEL; KTE-C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON-HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA-1. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_7] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S.S. Neelapu
- Department of Lymphoma and Myeloma, Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston USA
| | - F.L. Locke
- Blood and Marrow Transplant and Cellular Immunotherapy; H. Lee Moffitt Cancer Center; Tampa USA
| | - N.L. Bartlett
- Department of Medicine, Oncology Division, Medical Oncology Section; Washington University School of Medicine in St. Louis; St. Louis USA
| | - L.J. Lekakis
- Hematology/Oncology, University of Miami Health System; Sylvester Comprehensive Cancer Center; Miami USA
| | - D. Miklos
- Stanford University School of Medicine; Blood and Marrow Transplantation; Stanford USA
| | - C.A. Jacobson
- Hematologic Oncology; Dana-Farber Cancer Institute; Boston USA
| | - I. Braunschweig
- Department of Oncology; Montefiore Medical Center; Bronx USA
| | - O. Oluwole
- Department of Medicine; Vanderbilt University Medical Center; Nashville USA
| | - T. Siddiqi
- Department of Hematology & Hematopoietic Cell Transplantation; City of Hope, Duarte USA
| | - Y. Lin
- Department of Hematology; Mayo Clinic; Rochester USA
| | - J. Timmerman
- Department of Medicine; University of California at Los Angeles; Santa Monica USA
| | - P. Reagan
- Department of Medicine, Hematology/Oncology School of Medicine and Dentistry, University of Rochester School of Medicine; Wilmot Cancer Center; Rochester USA
| | | | - Y. Jiang
- N/A, Kite Pharma; Santa Monica USA
| | | | - M. Elias
- N/A, Kite Pharma; Santa Monica USA
| | | | - W.Y. Go
- N/A, Kite Pharma; Santa Monica USA
| |
Collapse
|
5
|
Neelapu S, Rossi J, Locke F, Xue A, Better M, Zhang X, Ghobadi A, Lekakis L, Miklos D, Jacobson C, Braunschweig I, Oluwole O, Siddiqi T, Lin Y, Timmerman J, Reagan P, Navale L, Go W, Wiezorek J, Bot A. PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI-CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI-CEL). Hematol Oncol 2017. [DOI: 10.1002/hon.2438_132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- S.S. Neelapu
- Department of Lymphoma and Myeloma, Division of Cancer Medicine; University of Texas MD Anderson Cancer Center; Houston USA
| | - J.M. Rossi
- Kite Pharma, Kite Pharma; Santa Monica USA
| | - F.L. Locke
- H. Lee Moffitt Cancer Center, H. Lee Moffitt Cancer Center; Tampa USA
| | - A. Xue
- Kite Pharma, Kite Pharma; Santa Monica USA
| | - M. Better
- Kite Pharma, Kite Pharma; Santa Monica USA
| | - X. Zhang
- Kite Pharma, Kite Pharma; Santa Monica USA
| | - A. Ghobadi
- Department of Medicine, Oncology Division, Bone Marrow Transplantation and Leukemia Section; Washington University School of Medicine in St. Louis; St. Louis USA
| | - L.J. Lekakis
- Hematology/Oncology; University of Miami Health System, Sylvester Comprehensive Cancer Center; Miami USA
| | - D. Miklos
- Blood and Marrow Transplantation; Stanford University School of Medicine; Stanford USA
| | - C.A. Jacobson
- Hematologic Oncology; Dana-Farber Cancer Institute; Boston USA
| | - I. Braunschweig
- Department of Oncology; Montefiore Medical Center, Albert Einstein College of Medicine; Bronx USA
| | - O. Oluwole
- Vanderbilt-Ingram Cancer Center, Vanderbilt-Ingram Cancer Center; Nashville USA
| | - T. Siddiqi
- City of Hope National Medical Center, City of Hope National Medical Center, Duarte; USA
| | - Y. Lin
- Department of Hematology; Mayo Clinic; Rochester USA
| | - J. Timmerman
- UCLA David Geffen School of Medicine; UCLA David Geffen School of Medicine; Los Angeles USA
| | - P.M. Reagan
- Department of Medicine, Hematology/Oncology (SMD); University of Rochester Medical Center; Rochester USA
| | - L. Navale
- Kite Pharma, Kite Pharma; Santa Monica USA
| | - W.Y. Go
- Kite Pharma, Kite Pharma; Santa Monica USA
| | | | - A. Bot
- Kite Pharma, Kite Pharma; Santa Monica USA
| |
Collapse
|
6
|
Oluwole O, Kirychuk SP, Lawson JA, Karunanayake C, Cockcroft DW, Willson PJ, Senthilselvan A, Rennie DC. Indoor mold levels and current asthma among school-aged children in Saskatchewan, Canada. Indoor Air 2017; 27:311-319. [PMID: 27108895 DOI: 10.1111/ina.12304] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2015] [Accepted: 04/12/2016] [Indexed: 06/05/2023]
Abstract
Current knowledge regarding the association between indoor mold exposures and asthma is still limited. The objective of this case-control study was to investigate the relationship between objectively measured indoor mold levels and current asthma among school-aged children. Parents completed a questionnaire survey of health history and home environmental conditions. Asthma cases had a history of doctor-diagnosed asthma or current wheeze without a cold in the past 12 months. Controls were age- and sex-matched to cases. Vacuumed dust samples were collected from the child's indoor play area and mattress. Samples were assessed for mold levels and quantified in colony-forming units (CFU). Sensitization to mold allergens was also determined by skin testing. Being a case was associated with family history of asthma, pet ownership, and mold allergy. Mold levels (CFU/m2 ) in the dust samples of children's mattress and play area floors were moderately correlated (r = 0.56; P < 0.05). High mold levels (≥30 000 CFU/m2 ) in dust samples from play [adjusted odds ratio (aOR) = 2.6; 95% CI: 1.03-6.43] and mattress (aOR) = 3.0; 95% CI: 1.11-8.00) areas were significantly associated with current asthma. In this study high levels of mold are a risk factor for asthma in children.
Collapse
Affiliation(s)
- O Oluwole
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - S P Kirychuk
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
- Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - J A Lawson
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
- Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - C Karunanayake
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - D W Cockcroft
- Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - P J Willson
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
- Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada
| | - A Senthilselvan
- School of Public Health, University of Alberta, Edmonton, AB, Canada
| | - D C Rennie
- Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
- College of Nursing, University of Saskatchewan, Saskatoon, SK, Canada
| |
Collapse
|
7
|
Neelapu S, Locke F, Bartlett N, Siddiqi T, Braunschweig I, Lekakis L, Goy A, Castro J, Oluwole O, Miklos D, Timmerman J, Jacobson C, Reagan P, Flinn I, Farooq U, Stiff P, Navale L, Elias M, Wiezorek J, Go W. ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw375.38] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Akinadenekan A, Adegbola A, Ajayi GO, Oluwole O. Prophylactic cervical cerclage under valium, phenergan, fortwin medication on prolongation of pregnancy. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Oluwole O, Arinola OG, Falade GA, Ige MO, Falusi GA, Aderemi T, Huo D, Olopade IO, Olopade CO. Allergy sensitization and asthma among 13-14 year old school children in Nigeria. Afr Health Sci 2013; 13:144-53. [PMID: 23658581 DOI: 10.4314/ahs.v13i1.20] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND The prevalence of asthma and role of atopy in asthma among children has not been clearly defined in Nigeria. OBJECTIVE To determine the prevalence of asthma and investigate risk factors related to allergy sensitization among urban and rural school children in southwest Nigeria. METHODS Validated ISAAC questionnaire was administered to 1736 high school children in randomly selected schools in rural and urban communities. Identified asthma cases were matched to controls. Allergy skin tests, blood eosinophil count, serum IgE and stool examination for parasites were performed. Dust samples from homes were also collected and analyzed for allergens. RESULTS The prevalence of asthma was 7.5% (95% CI 6.0 to 9.2%) and 8% (95% CI 6.0-10.4%) in the rural and urban communities respectively . Risk factors for asthma included cigarette-smoking, cats in the home and family size. Eosinophil count (109/L) was elevated in asthmatics [0.70 (95% CI 0.48-1.11) vs. 0.32 (95% CI 0.19-0.69); p<0.01], but IgE levels were similar between the two groups (298±229 IU/mL vs. 288±257; p=0.97). Positive skin tests to cat hair, cockroach, mango blossom and mouse epithelium were more frequent in asthmatics than in healthy controls, especially in the rural communities. There was no correlation between allergens in dust collected from homes and skin test reactivity. CONCLUSION Asthma prevalence is similar in rural and urban children in Southwest Nigeria and atopy with elevated IgE was not observed to be a major factor for asthma in our cohort of children in both communities.
Collapse
Affiliation(s)
- O Oluwole
- The Center for Global Health Initiative, University of Chicago, Chicago, IL, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Ige OM, Arinola OG, Oluwole O, Falade AG, Falusi AG, Aderemi T, Huo D, Olopade OI, Olopade CO. Atopy is associated with asthma in adults living in rural and urban southwestern Nigeria. J Asthma 2011; 48:894-900. [PMID: 21861770 DOI: 10.3109/02770903.2011.608458] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
RATIONALE Factors affecting the course of asthma are not clearly understood in rural and urban communities within low-resource countries. Furthermore, the interactions between atopy, environmental exposure, and helminthic infections in modulating asthma have not been well investigated. OBJECTIVES To conduct a feasibility study to examine the relationship between atopy and asthma in adults at two rural Health Centers and urban university college hospital in southwestern Nigeria. METHODS A convenient sample of 55 consecutive patients with stable physician-diagnosed asthma and 55 age-matched nonasthmatic controls seen at the outpatient clinics in two rural Health Centers and an urban university hospital were enrolled. All subjects underwent blood test, allergy skin test, and stool examination for ova and parasites. Wilcoxon sign-rank tests were used to compare serum eosinophilia and allergy skin test between the two groups. RESULTS Asthmatics in both urban and rural settings had significantly more positive skin reactions to house dust mite, cockroach, mold, and mouse epithelium than nonasthmatic controls (p < .05). Mean total serum IgE was also significantly higher in asthmatics than in nonasthmatic controls (360 vs. 90 IU/L, p <.001). Stool parasitemia was infrequent in both groups and not statistically significant. CONCLUSION Atopy is associated with adult asthma in southwest Nigeria. Larger studies to confirm the nature of this association and to examine the role of helminthic infection and other environmental factors on the expression of asthma are needed.
Collapse
Affiliation(s)
- O M Ige
- College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Ogun SA, Oluwole O, Fatade B, Ogunseyinde AO, Ojini FI, Odusote KA. Comparison of Siriraj Stroke Score and the WHO criteria in the clinical classification of stroke subtypes. Afr J Med Med Sci 2002; 31:13-6. [PMID: 12518923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
Clinical distinction between cerebral haemorrhage (CH) and cerebral infarction (CI) is important in the management of stroke patients in areas where CT scan facility is lacking or access limited by cost and distance. This distinction is necessary in our environment where an increasing proportion of patients are suspected to have haemorrhagic stroke. This study compares Siriraj stroke score (SSS) and the WHO criteria for the acute stroke syndrome as simple tools for this purpose. The computerised tomography (CT) brain scans of all patients referred with clinical diagnosis of stroke at the University College Hospital (UCH), Ibadan, and RADMED diagnostic centre. Lagos were retrieved and reviewed as well as the case notes of these patients at the referral hospitals. Relevant clinical data were extracted from the case records. The patients were classified into either CI or CH using the WHO criteria for acute stroke syndrome and the SSS. This classification was compared with the CT scan diagnosis using the latter as the gold standard. Data analysis was performed with Epi-info software, and Kappa statistics (k value) for comparability test with 95% confidence interval was used to compare the two clinical criteria with the gold standard. Ninety-six patients had complete clinical records and CT scan features consistent with the diagnosis of stroke, of which 52 were diagnosed as CI and 44 as CH. SSS had sensitivity of 50% for haemorrhage and 58% for infarction with an overall accuracy of 54.2%. The WHO criteria for the acute stroke syndrome had sensitivity of 73% for haemorrhage and 69% for infarction with an overall accuracy of 71%. The kappa coefficient was 0.18 for the SSS and 0.41 for the WHO criteria. The diagnostic accuracy of the WHO criteria for the acute stroke syndrome is higher than that of the Siriraj stroke score. The WHO criteria showed moderate agreement (k=0.41) with the CT scan, while the SSS showed no agreement (k=0.18). When CT scan is not affordable or its use is limited by distance, the WHO criteria for acute stroke syndrome could be more useful. A prospective study with a larger sample size is suggested for definitive conclusion.
Collapse
Affiliation(s)
- S A Ogun
- Dept. of Medicine, Ogun State University Teaching Hospital Sagamu, Nigeria
| | | | | | | | | | | |
Collapse
|
12
|
Ogun SA, Oluwole O, Ogunseyinde AO, Fatade B, Odusote KA. Misdiagnosis of stroke--a computerised tomography scan study. West Afr J Med 2000; 19:19-22. [PMID: 10821081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Misdiagnosis of stroke has significant implication for definitive therapy. This study assessed the frequency of misdiagnosis of stroke using computerised tomography (CT) scan of the brain. One hundred and fifty-six patients admitted over a five year period (1991-1996) with clinical features suggestive of stroke had their CT brain scan reviewed. Only 89 (57%) had neuroradiological features consistent with stroke, of which 59 (66%) had cerebral infarction while 30 (34%) had cerebral haemorrhage. In 67 (43%) of the cases, there were no features of cerebro-vascular accident (CVA) on the CT scan. In this group, cerebral atrophy was the commonest radiological abnormality (21/67), followed by brain tumor (10/67) and subdural haematoma (9/67). The CT scan was normal in 25 patients. The misdiagnosis of surgically treatable conditions in as many as 21 (13.5%) of the 156 patients calls for better neurological evaluation of patients admitted for stroke in tertiary and non-tertiary hospitals. Where available, patients with clinical diagnosis of stroke should have CT scan evaluation to ensure that patients who can be helped surgically are identified early and appropriately treated.
Collapse
Affiliation(s)
- S A Ogun
- Department of Medicine, Ogun State University Teaching Hospital, Sagamu, Nigeria
| | | | | | | | | |
Collapse
|